Type Here to Get Search Results !

India's cheap weight-loss drugs could reshape global obesity fight

With India’s semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market.

แสดงความคิดเห็น

0 ความคิดเห็น
* Please Don't Spam Here. All the Comments are Reviewed by Admin.